Past Trials

Assessment of fluoxetine in stroke recovery trial Lead PI:  Prof Graeme J Hankey and A/Prof Maree L. Hackett Status: Closed No….

A Phase 1b/2, Multi-Centre, Double-Blind, Placebo-Controlled, Randomized, Single-Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in…

A Very Early Rehabilitation Trial AVERT is a Phase III, international, multicentre, single blind trial comparing earlier onset and higher…

A Multicentre, Randomised, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects…

Extending the time for Thrombolysis in Emergency Neurological Deficits Phase III, randomised, multicentre, double blinded, placebo controlled trial (2 arm…

Extending the time for thrombolysis in emergency neurological deficits – intra-arterial with tenecteplase Lead PI: Dr Bruce Campbell Status: Closed  No. of…

Determining the Optimal Dose of Tenecteplase Before Endovacular Therapy for Ischaemic Stoke (EXTEND-IA TNK Part 2) Lead PI: Dr Bruce Campbell…

INternational Stroke Perfusion Imaging Registry INSPIRE: INternational Stroke Perfusion Imaging REgistry Lead PI:  John Hunter Hospital Status: Closed No. of Patients…

A Randomised, Double Blind, Placebo-controlled Phase II Multicentre Evaluation to Assess the Safety and Tolerability of DM199 Administered Intravenously and…

Randomised Efficacy and Safety Trial with Oral S 44819 after Recent ischaemic cerebral Event Lead PI: Prof Geoff Donnan Status: Closed to…

The Spot sign and Tranexamic acid on Preventing ICH growth- AUStralasia Trial Lead PI: Prof Geoff Donnan & Prof Steve Davis…

Randomised,Double-Blinded, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA…

Randomised,Double-Blinded, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA…

Very Early Rehabilitation in SpEech trial following stroke 2018 VERSE: Very Early Rehabilitation in SpEech trial following stroke  A prospective multicentre,…